| Literature DB >> 25913198 |
Vladimir A D'yakonov1, Lilya U Dzhemileva2, Aleksey A Makarov3, Alfiya R Mulukova3, Dmitry S Baev4, Elza K Khusnutdinova5, Tatiana G Tolstikova6, Usein M Dzhemilev3.
Abstract
(5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2Н-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2α) was determined.Entities:
Keywords: 5Z,9Z-Dienoic acids; DNA-binding; Molecular docking; Topoisomerase I; Topoisomerase IIα
Mesh:
Substances:
Year: 2015 PMID: 25913198 DOI: 10.1016/j.bmcl.2015.04.011
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823